IRIS
PATTAROZZI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.910
Totale 4.910
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.910
Totale 4.910
Salva come PNG Salva come JPEG
Città #
Genova 3.483
Genoa 523
Vado Ligure 461
Rapallo 434
Bordighera 9
Totale 4.910
Salva come PNG Salva come JPEG
Nome #
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects 203
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 177
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 165
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 159
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 158
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 157
Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis 152
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 149
SDF1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase, Pyk2. 144
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 139
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 138
Adiponectin as Novel Regulator of Cell Proliferation in Human Glioblastoma 134
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 130
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 129
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors 127
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 127
The phosphotyrosine phosphatase PTPh mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 125
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 122
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 120
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease 118
The Eighth Fibronectin Type III Domain of Protein Tyrosine Phosphatase Receptor J Influences the Formation of Protein Complexes and Cell Localization. 116
Chemokine stromal cell-derived factor 1α induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals 113
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 113
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 112
Differential role of EGF and bFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensitivity 112
Mutual influence of ROS, pH and CLIC1 membrane protein in the regulation of G1/S phase progression in human glioblastoma stem cells 112
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 111
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 108
Chronic lymphocytic leukemic (CLL) B cells express the HGF receptor (C-MET) and are supported in their survival by HGF-producing mesenchymal stromal cell 108
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 106
An intracellular multi-effector complex mediates somatostatin receptor 1 regulation of phospho-tyrosine phosphatase eta activity 104
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation 104
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation 100
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives 100
CXC receptors and chemokines expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation 97
17{beta}-ESTRADIOL PROMOTES BREAST CANCER CELL PROLIFERATION INDUCING SDF-1-MEDIATED EGFR TRANSACTIVATION: REVERSAL BY GEFITINIB PRE-TREATMENT. 92
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 83
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 81
Somatostatin receptors 1, 2 and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro, via a PTPh-dependent inhibition of ERK1/2. 77
The activation of the phosphotyrosine phosphatase h (r-PTPh) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 75
Somatostatin receptor subtype-dependent regulation of NO release: involvement of different intracellular pathways 57
The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation 45
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro 23
Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells 12
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function 8
Totale 5.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.232
article - articoli 15.232
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020722 0 0 0 0 0 0 175 77 112 185 139 34
2020/2021387 22 39 40 24 50 17 19 23 26 67 32 28
2021/2022578 27 55 28 62 20 39 35 135 32 41 22 82
2022/2023529 42 44 8 74 53 100 0 43 72 4 73 16
2023/2024355 16 29 6 43 21 90 35 17 17 12 15 54
2024/2025546 52 62 29 109 146 124 24 0 0 0 0 0
Totale 5.042